 BURLINGTON, Mass., June 09, 2021 GLOBE NEWSWIRE -- Flexion Therapeutics, Inc. Nasdaq:FLXN today announced that William T. Andrews, M.D., F.A.C.P., will join the company as Chief Medical Officer CMO, effective July 1, 2021. 